Erasca Stories Fourth Quarter 2021 Monetary Outcomes and Enterprise Updates | Information March 24, 2022 admin Financial E-learning 5 ongoing scientific trials evaluating candidates ERAS-007 (ERKi), ERAS-601 (SHP2i), and ERAS-801 (CNS-penetrant EGFRi) Preliminary Part 1b knowledge forHERKULES-1 and Part 1 knowledge for FLAGSHP-1 anticipated in H2 2022... Continue Reading
